It was observed that the length of time (period of follow-up) was significantly associated with FTS antigenemia seroreversion in the first follow-up (p < 0.001) but not the second (p = 0.132), with an increasing trend in participants becoming FTS-CFA negative [ Tables 3 and 4 ].
← all excerpts
Changes in circulating filarial antigen status in previously positive individuals: Lessons for treatment monitoring and pre-transmission assessment surveys.
2
—
—
The sentences
Regardless, the impact and influence of time on CFA seroreversion was highly significant in comparison to additional ivermectin/Albendazole intake.